Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots
Open accessThe DOI matches its Crossref record.
Abstract
Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots Jacqui WiseDenmark has temporarily suspended use of the Oxford-AstraZeneca covid-19 vaccine as a precautionary move after reports of blood clots and one death.However, the European Medicines Agency (EMA) and the UK's regulatory body have said that there is no indication that vaccination is linked to thromboembolic events.Eight other countries-Norway, Iceland, Austria, Estonia, Lithuania, Luxembourg, Italy, and Latvia-have also suspended use of AstraZeneca's vaccine.The decisions are a further setback for Europe's vaccination campaign, which has struggled to pick up speed, partly because of delays in delivering the AstraZeneca vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
Fernandes, Q., Inchakalody, V. P., Merhi, M., Mestiri, S., Taib, N., Moustafa Abo El-Ella, D., Bedhiafi, T., Raza, A., Al-Zaidan, L., Mohsen, M. O., et al. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2031274 · Cited by 447
Barros-Martins, J., Hammerschmidt, S. I., Cossmann, A., Odak, I., Stankov, M. V., Morillas Ramos, G., Dopfer-Jablonka, A., Heidemann, A., Ritter, C., Friedrichsen, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01449-9 · Cited by 425
Pottegård, A., Lund, L. C., Karlstad, Ø., Dahl, J., Andersen, M., Hallas, J., Lidegaard, Ø., Tapia, G., Gulseth, H. L., Ruiz, P. L.-D., et al. (2021) · BMJ · doi:10.1136/bmj.n1114 · Cited by 401
Yaseen, M. O., Saif, A., Khan, T. M., Yaseen, M., Saif, A., Bukhsh, A., Shahid, M. N., Alsenani, F., Tahir, H., Ming, L. C., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2031455 · Cited by 347
Pormohammad, A., Zarei, M., Ghorbani, S., Mohammadi, M., Razizadeh, M. H., Turner, D. L., & Turner, R. J. (2021) · Vaccines · doi:10.3390/vaccines9050467 · Cited by 339
Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis
Sharif, N., Alzahrani, K. J., Ahmed, S. N., & Dey, S. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714170 · Cited by 230
Li, X., Ostropolets, A., Makadia, R., Shoaibi, A., Rao, G., Sena, A. G., Martinez-Hernandez, E., Delmestri, A., Verhamme, K., Rijnbeek, P. R., et al. (2021) · BMJ · doi:10.1136/bmj.n1435 · Cited by 219
Will Africans take COVID-19 vaccination?
Anjorin, A. A., Odetokun, I. A., Abioye, A. I., Elnadi, H., Umoren, M. V., Damaris, B. F., Eyedo, J., Umar, H. I., Nyandwi, J. B., Abdalla, M. M., et al. (2021) · PLOS ONE · doi:10.1371/journal.pone.0260575 · Cited by 94
Bouillon, K., Baricault, B., Botton, J., Jabagi, M.-J., Bertrand, M., Semenzato, L., Le Vu, S., Drouin, J., Dray-Spira, R., Weill, A., et al. (2022) · BMJ Medicine · doi:10.1136/bmjmed-2021-000104 · Cited by 31
van der Boom, M. D. X., van Eekeren, R., & van Hunsel, F. P. A. M. (2023) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5610 · Cited by 11
“This was illustrated by the detected association between Thrombosis and Thrombocytopenia syndrome (TTS) and the AstraZeneca and Janssen vaccine after marketing authorization of the vaccines, which had consequences for the vaccination strategy in the Netherlands and other countries in Europe.11 Furthermore, since these…”
MethodParthasarathi, A., Puvvada, R. K., Basappa, S., Krishna, M. T., & P A, M. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17517.1 · Cited by 7
Metadata
- Authors
- Wise, J.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2021-03-11
- Volume
- 372
- Pages
- n699
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W3135716007
- Cited by
- 325
- References
- 0
- FWCI
- 22.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.